Peripheral ulcerative keratitis-like findings associated with filgrastim

Cornea

Volumn 26, Issue 3, 2007, Pages 368-369

  Fraunfelder, Frederick W ^a,c   Harrison, Devin ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Whidbey Eye Center   (United States)

^c or 97239 4197   (United States)

Author keywords

Filgrastim; Keratitis; Ocular side effects

Indexed keywords

ARTIFICIAL TEAR; DOXORUBICIN; GEMCITABINE; PACLITAXEL; PAMIDRONIC ACID; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

AGED; ANAMNESIS; ARTICLE; BREAST CANCER; CASE REPORT; CELL CULTURE; DRUG WITHDRAWAL; FEMALE; HUMAN; KERATITIS; NEUTROPENIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN DEFECT; SLIT LAMP; STAINING; TREATMENT WITHDRAWAL; VISUAL ACUITY;

AGED; CORNEAL ULCER; FEMALE; FILGRASTIM; HUMANS; INFUSIONS, INTRAVENOUS; RETROSPECTIVE STUDIES;

EID: 34147151603     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31802cd8f3     Document Type: Article

References (5)

1. Physician's Desk Reference. 60th ed. Neupogen. Montvale, NJ: Medical Economics Company; 2006.
2. Esmaeli B, Ahmadi MA, Kim S, et al. Marginal keratitis associated with administration of filgrastim and sargramostim in a healthy peripheral blood progenitor cell donor. Cornea. 2002;21:621-622.
3. Huhn RD, Yurkow EJ, Tushinski R. Recombinant human interleukin-3 enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor in normal volunteers. Exp Hematol. 1998;24:839-847.
4. Fraunfelder FW. Ocular side effects associated with bisphosphonates. Drugs of Today. 2003;39:829-835.
5. Thiebaud D, Sauty A, Burckhardt P, et al. An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int. 1997;61:386-392.